Income statement
USD
Annual
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 176M | 126M | 87M |
| Gross Profit | 135M | 94M | 58M |
| Operating Income | -64M | -61M | -73M |
| EBITDA | -55M | -65M | -63M |
| Net Income | -117M | -96M | -96M |
| EPS (Diluted) | — | — | — |
Healthcare
Live Price
Offline$35.65
+1.92% today
Window Change
+24.00%
Window
Aug 8, 2025 → Jun 26, 2026
Coverage: 221 bars · Aug 8, 2025 → Jun 26, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Heartflow, Inc. Common Stock (HTFL) is a Healthcare stock with a market cap of $2.55B and listed on NASDAQ. The stock last traded around $35.65 and up 24.0% across the available one-year price window (Aug 8, 2025 → Jun 26, 2026). Baseline metrics include revenue growth of +39.9%, EPS growth of +8.1%, a dividend yield of 0.0%. What stands out right now is revenue +39.9%, EPS +8.1%, free cash flow +19.5% with operating margin -36.4% and ROIC -19.8%. Valuation already assumes a fairly strong business story at price/sales 14.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines HTFL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
HTFL is 9.59 pts ahead over the shared 1Y window.
HTFL had 39.53 pts deeper max drawdown than SPY.
HTFL beat SPY in 1 of 2 calendar years shown and trailed in 1.
HTFL
+24.00%
Normalized return
SPY
+14.41%
S&P 500
Excess Return
+9.59 pts
Relative to SPY
HTFL Max Drawdown
-48.66%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for HTFL and SPY.
| Year | HTFL | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | +23.06% | +6.71% | +16.35 pts | HTFL |
| 2025 | +5.08% | +11.19% | -6.12 pts | SPY |
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$87.2M
-30.7% YoY
FY Net Income
-$95.7M
+0.8% YoY
Free Cash Flow
-$82.5M
-12.5% YoY
Revenue Growth
+39.9%
EPS Growth
+8.1%
Gross Margin
76.8%
Net Margin
-66.3%
Income statement
USD
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 176M | 126M | 87M |
| Gross Profit | 135M | 94M | 58M |
| Operating Income | -64M | -61M | -73M |
| EBITDA | -55M | -65M | -63M |
| Net Income | -117M | -96M | -96M |
| EPS (Diluted) | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash & Equivalents | 45M | 51M | 123M |
| Total Assets | 359M | 119M | 185M |
| Total Liabilities | 59M | 978M | 963M |
| Shareholder Equity | 301M | -859M | -778M |
| Total Debt | 22M | 160M | 161M |
| Net Debt | -23M | 109M | 38M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
76M
-10.8% YoY
Capital Expenditures
6M
-40.1% YoY
Free Cash Flow
83M
-12.5% YoY
Key ratios
Gross Margin
76.8%
Operating Margin
-36.4%
Net Margin
-66.3%
ROE
38.0%
Debt / Equity
0.07x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.